STOCK TITAN
  1. Home
  2. ARYD

ARYA Sciences Acquisition IV (ARYD) Stock Price, News & Analysis

ARYD NASDAQ

Company Description

ARYA Sciences Acquisition IV (NASDAQ: ARYD) is classified in the biological product (except diagnostic) manufacturing industry within the Blank Checks sector and carries a market capitalization of $50.0M, ranking #5,769 among all listed U.S. companies by market cap.

This page collects what Stock Titan holds for ARYD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$50.0M
Market Cap
3.8M
Shares outstanding

ARYA Sciences Acquisition IV (ARYD) stock last closed at $11.54. At a market capitalization of $50.0M, ARYD is classified as a micro-cap stock with approximately 3.8M shares outstanding.

See what a $1,000 investment in ARYD would be worth today

ARYD Rankings

Market Cap
$50.0M
#5,769

Latest News

View All
+3.94%

Adagio Medical Provides Business Updates

+36.30%

Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias

+0.90%

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

acquisition clinical trial
-1.41%

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

acquisition
—

ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering

IPO offering acquisition

ARYA Sciences Acquisition IV has 5 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, clinical trial, IPO, offering. View all ARYD news →

SEC Filings

View All

No SEC filings available for ARYD.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ARYD Company Profile & Sector Positioning

ARYA Sciences Acquisition IV (ARYD) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Blank Checks sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of ARYA Sciences Acquisition IV (ARYD)?

The current stock price of ARYA Sciences Acquisition IV (ARYD) is $11.54 as of September 4, 2024.

What is the market cap of ARYA Sciences Acquisition IV (ARYD)?

The market cap of ARYA Sciences Acquisition IV (ARYD) is approximately 50.0M. Learn more about what market capitalization means .